Evidence map›Paper›PMID 32402542›Full record

ArticleSurgery2020

Symptom relief and quality of life after combined partial hepatectomy and cyst fenestration in highly symptomatic polycystic liver disease.

Lucas H P Bernts, Myrte K Neijenhuis, Marie E Edwards, Jeff A Sloan, Jenna Fischer, Rory L Smoot, David M Nagorney, Joost P H Drenth, Marie C Hogan

Open access · greenAbstract read
In one paragraph

Article in Surgery, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 19 citations in OpenAlex.

  1. Transplant Indications in Polycystic Liver and Kidney DiseaseThe Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2026
    Review
  2. Article
  3. KDIGO 2025 ADPKD guideline: a commentary on diagnosis and management of hepatopancreatic manifestations by the ERA Working Group Genes & Kidney.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2025
    Article
  4. Segments 4, 7, and 8 liver resection: A case report.Annals of hepato-biliary-pancreatic surgery · 2024
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Lucas H P BerntsDepartment of Gastroenterology and Hepatology, Radboud University Nijmegen Medical Center, the Netherlands.
Myrte K NeijenhuisDepartment of Gastroenterology and Hepatology, Radboud University Nijmegen Medical Center, the Netherlands.
Marie E EdwardsDivision of Nephrology and Hypertension, Department of Internal Medicine, Mayo Clinic, Rochester, MN; Robert M. and Billie Kelley Pirnie Translational Polycystic Kidney Disease Center, Mayo Clinic, Rochester, MN.
Jeff A SloanQuality of Life Group, Department of Health Sciences Research, Mayo Clinic, Rochester, MN.
Jenna FischerDepartment of Surgery, Mayo Clinic, Rochester, MN.
Rory L SmootDepartment of Surgery, Mayo Clinic, Rochester, MN.
David M NagorneyDepartment of Surgery, Mayo Clinic, Rochester, MN.
Joost P H DrenthDepartment of Gastroenterology and Hepatology, Radboud University Nijmegen Medical Center, the Netherlands.
Marie C HoganDivision of Nephrology and Hypertension, Department of Internal Medicine, Mayo Clinic, Rochester, MN; Robert M. and Billie Kelley Pirnie Translational Polycystic Kidney Disease Center, Mayo Clinic, Rochester, MN. Electronic address: hogan.marie@mayo.edu.
Mayo Clinic in Arizona · USRadboud University Nijmegen · NLMayo Clinic · USMayo Clinic in Florida · US

Funding

Pilot and FeasibilityP30DK090728 · NIDDK · MAYO CLINIC ROCHESTER · PI ROMERO, MICHAEL F. · 2010 to 2019
$11.8M
NIDDK NIH HHS P30 DK090728
6 · The paper itself

Abstract

backgroundPolycystic liver disease can cause severe symptomatic hepatomegaly. Combined partial hepatectomy and cyst fenestration can be performed to reduce liver volume and symptom burden. We aimed to assess change in symptom relief and quality of life 6 months after partial hepatectomy and cyst fenestration in polycystic liver disease patients.

methodWe established a prospective cohort between 2014 and 2018 at a referral center in the United States. Patients who underwent partial hepatectomy and cyst fenestration for volume-related symptoms were included. Primary outcome was change in polycystic liver disease-related symptoms, measured with Polycystic Liver Disease Questionnaire. Secondary outcomes were change in liver volume (computed tomography/ magnetic resonance imaging) and change in quality of life, measured with the 12-Item Short Form Survey and the EuroQoL Visual Analogue Scale. Questionnaire scores range from 0 to 100 and were assessed before and 6 months after partial hepatectomy and cyst fenestration. Surgical complications were scored according to Clavien-Dindo (grade 1 to 5).

resultsWe included 18 patients (mean age 52 years, 82% female). Partial hepatectomy and cyst fenestration reduced median liver volume (4,917 to 2,120 mL). Symptoms, measured with Polycystic Liver Disease Questionnaire, decreased (76.9 to 34.8 points; P < .001) 6 months after surgery; 15/16 symptoms declined after treatment, with the most impact seen on early satiety and dyspnea. Quality of life also improved after surgery: median physical and mental component scales of the 12-Item Short Form Survey and EuroQoL Visual Analog Scale increased (24.9 to 45.7, P = .004; 40.5 to 55.4, P = .02; and 40.0 to 72.5, P = .003). Major complications (grade 4) occurred in 2 patients. There was no procedure-related mortality.

conclusionPartial hepatectomy and cyst fenestration substantially improves symptom burden and quality of life in highly symptomatic polycystic liver disease patients.

Indexed as

AdultCystsFemaleHepatectomyHumansLiver DiseasesMaleMiddle AgedProspective StudiesQuality of LifeTreatment Outcome

Identifiers

PMID32402542
PMCPMC7347464
OpenAlexW3021585795

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.